登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码：000538 股票简称：云南白药 公告编号：2026-06 云南白药集团股份有限公司关于认购云白国际有限公司可换股债券的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于2024年10月29日召开第十届董事会2024 年第十次会议，审议通过《关于云白国际可换股债券到期处理的议案》，同意根据公司与云白国际有限 公司（原名为"万隆控股集团有限公司"，以下简称"云白国际"）签订的《可换股债券认购协议之补充协 议》等相关协议之约定，对公司持有的5亿港元云白国际可换股债券行权转股，根据相关协议安排，公 司将在云白国际公众持股量满足转股要求后，按照确定的方案及操作流程实施后续的行权转股及所涉及 的信托产品相关事项。有关前述可换股债券具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）于 2020年10月29日披露的《关于委托第三方认购万隆控股集团有限公司可换股债券并签署补充协议（六） 暨关联交易的进展公告》（公告编号：2020-72 ...

股票代码：000538 股票简称：云南白药 公告编号：2026-06 基于云白国际当前的股权结构，公司持有的云白国际可换股债券转股后， 云白国际公众持股量仍将满足香港联合交易所有限公司证券上市规则规定 的最低公众持股量的要求，符合上述协议约定的转股条件，公司持有的云白 国际可换股债券可以进行行权转股。 2026 年 2 月 27 日，云白国际按换股价每股 0.258 港元向云南白药的指 定受托人上海国际信托有限公司（以下简称"上海信托"，代表云南白药认 购及持有可换股债券）配发及发行 1,937,984,496 股云白国际股份，占换股前 云白国际股份总数 7,599,914,160 股约 25.50%、占换股后云白国际股份总数 9,537,898,656 股约 20.32%。云白国际换股前后股权结构如下表所示： | 股东名称 | 换股前 | | 换股后 | | | --- | --- | --- | --- | --- | | | 股份数量 持股比例 | 股份数量 | | 持股比例 | | 云南白药（注 1） | 1,908,025,360 | 25.11% 3,846,009,856 | | 40.32% ...

智通财经APP讯，云白国际(00030)发布公告，于2026年2月27日，本公司按换股价每股换股股份0.258港 元向上海国际信托有限公司(上海信托，云南白药集团股份有限公司(云南白药集团)指定的受托人，代表 云南白药集团认购及持有可换股债券)悉数配发及发行19.38亿股换股股份，占紧接发行换股股份前已发 行股份总数约25.50%及紧随发行换股股份后经扩大已发行股份总数约20.32%。换股股份为上海信托代 表云南白药集团及作为其受托人持有。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近日接到公司股东新华都实业集团股份 有限公司（以下简称"新华都"）的通知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如 下： 一、本次股份质押基本情况 上述股份质押事项若出现其他重大变动情况，公司将按照有关规定及时履行信息披露义务。 ■ 质押股份是否负担重大资产重组等业绩补偿义务：否。 二、股东股份累计质押情况 截至本公告披露日，新华都及其一致行动人所持质押股份情况如下： ■ 注：1、新华都持股数量、持股比例、质押股份数量等相关数据，均考虑了新华都通过非公开发行可交 换公司债券开立的"新华都集团-国信证券-25新华都EB01担保及信托财产专户"所持有的云南白药股份 5,600万股； 2、除上述担保及信托专户外，新华都的一致行动人所持云南白药股份均不存在质押情形。 截至本公告披露日，新华都及其一致行动人持有云南白药股份数量为 449,624,311股，本次质押股数为 7,470,000股，占新华都 ...

证券日报网讯 2月25日，云南白药发布公告称，公司于近日接到公司股东新华都实业集团股份有限公司 （简称"新华都"）的通知，获悉新华都将其持有的公司部分股份办理了质押，本次质押数量为7，470， 000股。 （文章来源：证券日报） ...

云南白药集团股份有限公司 关于股东部分股份质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"云南白药"）于近 日接到公司股东新华都实业集团股份有限公司（以下简称"新华都"）的通 知，获悉新华都将其持有的公司部分股份办理了质押。具体情况如下： 股票代码：000538 股票简称：云南白药 公告编号：2026-05 质押股份是否负担重大资产重组等业绩补偿义务：否。 1 / 3 股东名 称 是否为控 股股东或 第一大股 东及其一 致行动人 本次质押数 量（股） 占其所 持股份 比例 占公司 总股本 比例 是否为限 售股（如 是，注明 限 售 类 型） 是否 为补 充质 押 质押起始日 质押 到期 日 质权人 质押 用途 新华都 实业集 团股份 有限公 司 否 7,470,000 1.71% 0.42% 否 否 2026-02-13 至办 理解 除质 押之 日止 中国建 设银行 股份有 限公司 福州五 一支行 融资 担保 合计 / 7,470,000 1.71% 0.42% / / / / / / 一、本次股份质押 ...

Core Insights - The article emphasizes the growing popularity of Huangjing due to its health benefits, particularly in nourishing the body and enhancing vitality, while highlighting the importance of selecting high-quality brands based on purity and traditional processing methods [1][3]. Evaluation Criteria and Assessment - A comprehensive seven-dimensional evaluation system was established, focusing on authenticity, practicality, and scientific basis to ensure reliable conclusions [4]. - The assessment covered aspects such as raw material authenticity, traditional processing adherence, core ingredient content, formulation purity, certification completeness, user feedback, and overall value [5][6]. Annual Preferred Brands Summary - The top-rated brand, Luoyunfeng Huangjing, is noted for its adherence to traditional methods and high-quality raw materials, achieving a benchmark in polysaccharide content [8]. - Other notable brands include Fengyitang Huangjing, Beijing Tongrentang Huangjing, and Yunnan Baiyao Huangjing, each recognized for their unique sourcing and processing techniques [8][9][10][11][12][13][14][15]. Detailed Brand Insights - Luoyunfeng Huangjing is sourced from the Qinling region, with over five years of growth, and follows a meticulous traditional processing method known as "True Nine System," resulting in a rich and pure product [17][19]. - The brand boasts a polysaccharide content of nearly 40% and a saponin content increase of 42%, setting a new standard in quality among Huangjing products [19]. - Luoyunfeng's formulation is strictly composed of Huangjing with zero additives, ensuring a clean and natural product [19][20]. User Feedback and Market Position - Users reported significant improvements in energy levels and overall well-being after consistent use of Luoyunfeng Huangjing, reinforcing its reputation for quality and effectiveness [21][22]. - The product is particularly suitable for individuals with demanding lifestyles, such as office workers and the elderly, due to its gentle and nourishing properties [22][23]. Value Proposition - Luoyunfeng Huangjing offers a balance of high quality and reasonable pricing, making it an attractive option for consumers seeking effective health supplements without excessive brand premiums [23]. - The brand also engages in social responsibility by donating a portion of sales to support education for underprivileged girls, enhancing its appeal beyond just product quality [25]. Conclusion - The evaluation concludes that the essential criteria for high-quality Huangjing remain consistent: authentic sourcing, adequate aging, traditional processing, and pure formulations [36]. Luoyunfeng Huangjing exemplifies these standards, making it a reliable choice for consumers seeking effective health solutions.

Core Viewpoint - Yunnan Shennong Agricultural Industry Group Co., Ltd. has signed a strategic cooperation framework agreement with Yunnan Baiyao Group Co., Ltd. to leverage their respective strengths in traditional medicine and agricultural development [1] Group 1: Company Overview - Yunnan Baiyao is a well-known national brand that focuses on traditional medicine products, aiming to innovate and meet modern health needs while promoting high-quality development of traditional Chinese medicine [1] - Shennong Group is focused on the entire pig industry chain development, aligning its health-oriented philosophy with Yunnan Baiyao's mission of health and vitality [1] Group 2: Strategic Collaboration - The collaboration aims to utilize Yunnan's unique plant resources to integrate various resources such as platforms, talent, technology, and brands [1] - The partnership will explore innovative models combining "special plant resources + modern agriculture," enhancing the application of traditional Chinese medicinal herbs in livestock farming [1] - The goal is to improve green and healthy farming practices, providing consumers with safer and healthier products [1]

Group 1 - The core viewpoint of the article is the strategic cooperation agreement signed between Yunnan Baiyao Group Traditional Chinese Medicine Resources Co., Ltd. and Yunnan Shennong Agricultural Industry Group Co., Ltd. [1] - The collaboration will focus on advancing the application of traditional Chinese medicine resources in animal nutrition, disease prevention, and "antibiotic-free farming" [1]

Group 1: Core Insights - Yunnan Baiyao held its first board meeting of 2026 on February 10, approving several key proposals including a 137 million yuan investment in the second phase of the Wenshan company's oral liquid project to enhance production capacity for products like Qixuekang, aligning with the strategy to develop a series of major products [1] - The company also approved a 2026 organizational structure plan and appointed Dong Ming as the president and Qian Yinghui as the board secretary, aimed at strengthening strategic implementation and operational support [1] - Additionally, the appointment of Zhu Zhaoyun as a strategic scientist in traditional Chinese medicine and Zhang Ning as the chief scientist was announced to enhance the research and development system, which may positively impact the company's long-term business layout and governance efficiency [1] Group 2: Recent Events - Over the past week (as of February 11, 2026), Yunnan Baiyao's stock price showed slight fluctuations, closing at 57.25 yuan on February 10, down 0.14% for the day, while institutional funds net bought 15.16 million yuan, accounting for 4.17% of the total trading volume, indicating inflow from institutional investors [2] - The latest stock price on February 11 was 57.21 yuan, reflecting a minor decline of 0.07%, with a trading volume of approximately 154 million yuan and a turnover rate of 0.15% [2] - On February 10, retail and speculative funds saw net outflows of 11.31 million yuan and 3.86 million yuan respectively, contrasting with the inflow from institutional funds, while the stock price approached a 20-day resistance level of 57.52 yuan, with MACD indicators suggesting short-term bullish sentiment [2] Group 3: Financial Report Analysis - According to the Q3 2025 financial report, Yunnan Baiyao's revenue for the first three quarters was 30.654 billion yuan, representing a year-on-year increase of 2.47%, while net profit attributable to shareholders was 4.777 billion yuan, up 10.41% year-on-year, and the net profit excluding non-recurring items was 4.55 billion yuan, increasing by 6.68% [3] - Revenue for the single third quarter saw a slight decline of 0.66%, but net profit continued to grow, indicating effective cost control [3] - The company's debt ratio remained low at 25.36%, with a gross profit margin of 30.06%, reflecting a robust financial structure [3]